Positron comments on new medical radiation bill passed into law in California

NewsGuard 100/100 Score

Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, commented on the new medical radiation bill passed into law in California.  

Last week, Governor Arnold Schwarzenegger of California signed a medical radiation protection bill (SB1237) into law, paving the way for implementation of the first state law in the U.S. aimed at protecting patients from excessive radiation exposure received during CT scans and radiation therapy procedures. The law's passage comes on the heels of an overwhelming increase of reported incidents of patients being exposed to excess radiation both in California and throughout the country.  

"We believe the passage of this bill will create awareness, and generate further discussion on the proper guidelines and procedures on minimizing radiation exposure to patients. Positron is well-positioned to be in accordance with the new California regulations by offering customers a CT-free solution with our Attrius dedicated PET scanner. The Attrius was specifically engineered to address the underlying consensus of the radiology community – to follow the ALARA principal (as low as reasonably achievable), in reducing radiation exposure to the lowest level possible.

"This is not an issue specific to California; we are pleased to offer a safe viable alternative to the greater medical community," stated Joseph Oliverio, CTO of Positron.

SB 1237, which the governor signed without comment, will impose strict new procedures and reporting requirements to protect patients from medical radiation overdoses when it becomes effective July 1, 2012.

SOURCE Positron Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough imaging method enhances precision in prostate cancer treatment